scholarly article | Q13442814 |
P2093 | author name string | Nakopoulou L | |
Stefanaki K | |||
Giannopoulou I | |||
Filaktopoulos D | |||
P433 | issue | 4 | |
P921 | main subject | immunohistochemistry | Q899285 |
hepatocellular carcinoma | Q1148337 | ||
P304 | page(s) | 677-682 | |
P577 | publication date | 1994-10-01 | |
P1433 | published in | Histology & Histopathology | Q13726949 |
P1476 | title | C-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study | |
P478 | volume | 9 |
Q34611637 | A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomas |
Q36622264 | Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma |
Q28078111 | HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists |
Q41902323 | Immunohistochemical study on p53, H-rasp21, c-erbB-2 protein and PCNA expression in HCC tissues of Han and minority ethnic patients |
Q35588545 | Overexpression/amplification of HER-2/neu is uncommon in hepatocellular carcinoma |
Q64279990 | Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence |
Q36708741 | Sorafenib: where do we go from here? |
Q42180761 | TOP2A amplification and overexpression in hepatocellular carcinoma tissues. |
Q35207561 | Targeted therapy in hepatocellular carcinoma |
Q36395424 | The Predictive and Prognostic Significance of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 Expression in Hepatocellular Carcinoma |
Search more.